Metabolomics and Disease Markers

Metabolomics and Disease Markers
Metabolomics, a recent addition to the omics technologies refers to profiling of metabolites that are small molecular weight entities (50-1000 Da) present in given samples. In the systems biology cascade, metabolomics reflects the final output thus it can provide the information that complements other omics techniques such as genomics, transcriptomics and proteomics. As metabolomics gets its contribution from environmental, genetic and pathological factors, it represents changes in phenotypic and molecular physiology. Metabolomics can provide a real-time snapshot of the molecular events fabricated by the disease. Altered metabolism is one of the emerging hallmarks of various diseases and hence, metabolomics can assist in early detection of the diseases. Therefore, metabolomics is a rapidly emerging field in the sector of disease markers. The session of metabolomics and disease markers would highlight some of the advanced ongoing research in this rapidly developing omics field.


Dr. Arun Sreekumar
Baylor College of Medicine, Houston, Texas, United States

Dr. Putluri Nagireddy
Baylor College of Medicine, Houston, Texas, United States

Dr. Siddhesh Kamat
Indian Institute of Science Education and Research, Pune, India

Dr. S. Prabhakar
CSIR-Indian Institute of Chemical Technology, Hyderabad, India

Dr. S. Venketesh
Sri Sathya Sai Institute of Higher Learning, Andhra Pradesh, India